![](/img/cover-not-exists.png)
A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors
Tse, A. N., Klimstra, D. S., Gonen, M., Shah, M., Sheikh, T., Sikorski, R., Carvajal, R., Mui, J., Tipian, C., O'Reilly, E., Chung, K., Maki, R., Lefkowitz, R., Brown, K., Manova-Todorova, K., Wu, N.,Volume:
14
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-08-1006
Date:
October, 2008
File:
PDF, 434 KB
english, 2008